share_log

Genprex Collaborators To Present Preclinical Data On Use Of Reqorsa And On NPRL2 Gene Therapy Utilizing Non-Viral Oncoprex Delivery System For Lung Cancers At 2024 AACR Annual Meeting

Moomoo 24/7 ·  Mar 6 08:36

Reqorsa Immunogene Therapy May be a Potential Therapy for ALK-Positive Lung Cancer

REQORSA has Anti-Tumor Mechanisms that Target and Disrupt the Metabolism of Cancer Cells

NPRL2 Gene Therapy Induces Effective Anti-Tumor Immunity in Non-Small Cell Lung Cancer Humanized Mouse Model

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment